Mavacamten Favorably Impacts Cardiac Structure in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM Cardiac Magnetic Resonance Substudy Analysis

Saved in:
Bibliographic Details
Published in:Circulation (New York, N.Y.) N.Y.), 2021-02, Vol.143 (6), p.606-608
Main Authors: Saberi, Sara, Cardim, Nuno, Yamani, Mohamad, Schulz-Menger, Jeanette, Li, Wanying, Florea, Victoria, Sehnert, Amy J., Kwong, Raymond Y., Jerosch-Herold, Michael, Masri, Ahmad, Owens, Anjali, Lakdawala, Neal K., Kramer, Christopher M., Sherrid, Mark, Seidler, Tim, Wang, Andrew, Sedaghat-Hamedani, Farbod, Meder, Benjamin, Havakuk, Ofer, Jacoby, Daniel
Format: Article
Language:English
Subjects:
Benzylamines - pharmacology
Benzylamines - therapeutic use
Cardiomyopathy, Hypertrophic - diagnostic imaging
Cardiomyopathy, Hypertrophic - drug therapy
Female
Humans
Magnetic Resonance Imaging, Cine - methods
Male
Middle Aged
Uracil - analogs & derivatives
Uracil - pharmacology
Uracil - therapeutic use
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0009-7322
1524-4539
DOI:10.1161/CIRCULATIONAHA.120.052359